A study on vancomycin treatment, new data on the investigational Pfizer C diff vaccine, how individual antibiotics are ranked by risk for C difficile infection, and more.
C diff Treatment: Fidaxomicin's Rise as The Preferred Therapy Post-IDSA Guidelines
C difficile, Antimicrobials, and the Patients Most Affected
Top 5 Infectious Disease News Stories Week of September 20-27
Investigational C Diff Therapy Shows Favorable Microbiome Characteristics, Phase 3 Trial Planned
FMT Trial Shows Limited Efficacy for C difficile Recurrences
Diverse Genotypes of Clostridioides difficile Revealed